Sidekick Health Advances Menopause Care with MENO! App Launch
Reykjavik, Friday, 14 March 2025.
Sidekick Health introduces the MENO! App for menopausal symptom relief, marking a significant step in women’s health with a 12-week trial in Germany offering CBT solutions.
Pioneering Digital Therapeutics for Menopause
On March 9, 2025, Sidekick Health launched a groundbreaking clinical study for its MENO! App, positioning it as one of the first CE-marked digital therapeutics specifically designed for menopause management [1]. The initiative addresses a critical healthcare gap, as one in four women experience severe menopausal symptoms that significantly impact their quality of life and work capability [2]. The digital therapeutic combines evidence-based cognitive behavioral therapy (CBT) with comprehensive lifestyle support, offering a non-hormonal alternative to traditional menopause treatments [1][2].
Clinical Validation and Market Presence
The 12-week decentralized randomized-controlled study, currently underway in Germany, targets women aged 40-65 experiencing significant menopausal symptoms [1]. Sidekick Health’s strong presence in the German market is evidenced by its network of 16,000 healthcare providers and over 100,000 issued prescriptions [2]. The study is expected to conclude by June 1, 2025, after which the control group will also gain access to the app, ensuring equitable distribution of benefits [1].
Expert Leadership and Future Vision
Prof. Dr. Pia Wülfing, Sidekick Health’s chief clinical officer and licensed OB/GYN, emphasizes the company’s commitment to combining technology with medical expertise to improve healthcare outcomes [2]. The MENO! App represents the next phase in Sidekick’s mission to deliver evidence-based, scalable digital health solutions, with plans to expand from Germany to global markets [2]. This initiative builds upon Sidekick’s successful track record in chronic disease management, oncology, and maternity care [1].